Glycogen synthetase kinase 3 inhibition drives MIC‐A/B to promote cytokine production by human natural killer cells in Dengue virus type 2 infection

Dengue virus (DENV) is the most widespread arbovirus worldwide and is responsible for major outbreaks. The host's immune response plays a crucial role in controlling this infection but might also contribute to the promotion of viral spread and immunopathology. In response to DENV infection, NK cells preferentially produce cytokines and are cytotoxic in the presence of specific antibodies. Here, we identified that DENV‐2 inhibits glycogen synthase kinase 3 (GSK‐3) activity to subsequently induce MHC class‐1‐related chain (MIC) A and MIC‐B expression and IL‐12 production in monocyte‐derived DCs, independently of the STAT‐3 pathway. The inhibition of GSK‐3 by DENV‐2 or small molecules induced MIC‐A/B expression on monocyte‐derived DCs, resulting in autologous NK cells of a specific increase in IFN‐γ and TNF‐α production, in the absence of direct cytotoxicity. Together, these findings identified GSK‐3 as a regulator of MIC‐A/B expression and suggested its role in DENV‐2 infection to specifically induce cytokine production by NK cells. High production of IFN‐γ and TNF‐α by NK cells is specifically drive by an overexpression of MHC class‐1‐related chain (MIC)‐A/B in monocytes‐derived dendritic cells (Mo‐DCs) infected by Dengue virus type 2 (DV‐2). Mechanistically, DV‐2 inhibits glycogen synthase kinase 3 (GSK‐3) activity to subsequently induced MIC‐A expression in Mo‐DCs.